These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 28236969)
21. Activator or inhibitor? GSK-3 as a new drug target. Takahashi-Yanaga F Biochem Pharmacol; 2013 Jul; 86(2):191-9. PubMed ID: 23643839 [TBL] [Abstract][Full Text] [Related]
22. NK cell function triggered by multiple activating receptors is negatively regulated by glycogen synthase kinase-3β. Kwon HJ; Kwon SJ; Lee H; Park HR; Choi GE; Kang SW; Kwon SW; Kim N; Lee SY; Ryu S; Kim SC; Kim HS Cell Signal; 2015 Sep; 27(9):1731-41. PubMed ID: 26022178 [TBL] [Abstract][Full Text] [Related]
23. The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death. Hongisto V; Vainio JC; Thompson R; Courtney MJ; Coffey ET Mol Cell Biol; 2008 Mar; 28(5):1515-27. PubMed ID: 18195042 [TBL] [Abstract][Full Text] [Related]
24. Natural and synthetic bioactive inhibitors of glycogen synthase kinase. Khan I; Tantray MA; Alam MS; Hamid H Eur J Med Chem; 2017 Jan; 125():464-477. PubMed ID: 27689729 [TBL] [Abstract][Full Text] [Related]
26. RIFLE: a novel ring zinc finger-leucine-rich repeat containing protein, regulates select cell adhesion molecules in PC12 cells. Li B; Su Y; Ryder J; Yan L; Na S; Ni B J Cell Biochem; 2003 Dec; 90(6):1224-41. PubMed ID: 14635195 [TBL] [Abstract][Full Text] [Related]
27. Wnt Signaling Regulates Blood Pressure by Downregulating a GSK-3β-Mediated Pathway to Enhance Insulin Signaling in the Central Nervous System. Cheng PW; Chen YY; Cheng WH; Lu PJ; Chen HH; Chen BR; Yeh TC; Sun GC; Hsiao M; Tseng CJ Diabetes; 2015 Oct; 64(10):3413-24. PubMed ID: 25883115 [TBL] [Abstract][Full Text] [Related]
28. Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Doble BW; Patel S; Wood GA; Kockeritz LK; Woodgett JR Dev Cell; 2007 Jun; 12(6):957-71. PubMed ID: 17543867 [TBL] [Abstract][Full Text] [Related]
29. The neuron-specific isoform of glycogen synthase kinase-3beta is required for axon growth. Castaño Z; Gordon-Weeks PR; Kypta RM J Neurochem; 2010 Apr; 113(1):117-30. PubMed ID: 20067585 [TBL] [Abstract][Full Text] [Related]
30. Signaling pathways mediating phosphorylation and inactivation of glycogen synthase kinase-3β by the recombinant human δ-opioid receptor stably expressed in Chinese hamster ovary cells. Olianas MC; Dedoni S; Onali P Neuropharmacology; 2011 Jun; 60(7-8):1326-36. PubMed ID: 21276805 [TBL] [Abstract][Full Text] [Related]
31. Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation. Neumann M; Klar S; Wilisch-Neumann A; Hollenbach E; Kavuri S; Leverkus M; Kandolf R; Brunner-Weinzierl MC; Klingel K Oncogene; 2011 May; 30(21):2485-92. PubMed ID: 21217772 [TBL] [Abstract][Full Text] [Related]
32. Andrographolide activates the canonical Wnt signalling pathway by a mechanism that implicates the non-ATP competitive inhibition of GSK-3β: autoregulation of GSK-3β in vivo. Tapia-Rojas C; Schüller A; Lindsay CB; Ureta RC; Mejías-Reyes C; Hancke J; Melo F; Inestrosa NC Biochem J; 2015 Mar; 466(2):415-30. PubMed ID: 25423492 [TBL] [Abstract][Full Text] [Related]
33. Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway. Garrido JL; Godoy JA; Alvarez A; Bronfman M; Inestrosa NC FASEB J; 2002 Dec; 16(14):1982-4. PubMed ID: 12397090 [TBL] [Abstract][Full Text] [Related]
34. Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase. Wang Q; Zhou Y; Wang X; Evers BM Oncogene; 2006 Jan; 25(1):43-50. PubMed ID: 16278684 [TBL] [Abstract][Full Text] [Related]
35. Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2. Yamamoto H; Yoo SK; Nishita M; Kikuchi A; Minami Y Genes Cells; 2007 Nov; 12(11):1215-23. PubMed ID: 17986005 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of Improved Glycogen Synthase Kinase-3α Inhibitors in Models of Acute Myeloid Leukemia. Neumann T; Benajiba L; Göring S; Stegmaier K; Schmidt B J Med Chem; 2015 Nov; 58(22):8907-19. PubMed ID: 26496242 [TBL] [Abstract][Full Text] [Related]
37. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734 [TBL] [Abstract][Full Text] [Related]
38. Apical membrane localization of glycogen synthase kinase 3beta protein in normal colon epithelium and aberrant distribution in colorectal cancer. Hirakawa H; Nakayama T; Shibata K; Mihara Y; Taba M; Nagayasu T; Sekine I Cancer Lett; 2009 Mar; 275(1):158-62. PubMed ID: 19022564 [TBL] [Abstract][Full Text] [Related]
39. Glycogen synthase kinase-3 (Gsk-3) plays a fundamental role in maintaining DNA methylation at imprinted loci in mouse embryonic stem cells. Meredith GD; D'Ippolito A; Dudas M; Zeidner LC; Hostetter L; Faulds K; Arnold TH; Popkie AP; Doble BW; Marnellos G; Adams C; Wang Y; Phiel CJ Mol Biol Cell; 2015 Jun; 26(11):2139-50. PubMed ID: 25833708 [TBL] [Abstract][Full Text] [Related]
40. Glycogen synthase kinase-3β (GSK-3β) and its dysregulation in glioblastoma multiforme. Atkins RJ; Stylli SS; Luwor RB; Kaye AH; Hovens CM J Clin Neurosci; 2013 Sep; 20(9):1185-92. PubMed ID: 23768967 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]